PLoS ONE (Jan 2021)

LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples

  • Elizabeth C. Stahl,
  • Allan R. Gopez,
  • Connor A. Tsuchida,
  • Vinson B. Fan,
  • Erica A. Moehle,
  • Lea B. Witkowsky,
  • Jennifer R. Hamilton,
  • Enrique Lin-Shiao,
  • Matthew McElroy,
  • Shana L. McDevitt,
  • Alison Ciling,
  • C. Kimberly Tsui,
  • Kathleen Pestal,
  • Holly K. Gildea,
  • Amanda Keller,
  • Iman A. Sylvain,
  • Clara Williams,
  • Ariana Hirsh,
  • Alexander J. Ehrenberg,
  • Rose Kantor,
  • Matthew Metzger,
  • Kara L. Nelson,
  • Fyodor D. Urnov,
  • Bradley R. Ringeisen,
  • Petros Giannikopoulos,
  • Jennifer A. Doudna,
  • IGI Testing Consortium

Journal volume & issue
Vol. 16, no. 11

Abstract

Read online

Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2–3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.